terazosin BPH
Selected indexed studies
- The efficacy and safety of terazosin for the treatment of symptomatic BPH. (Prostate, 1991) [PMID:1711689]
- Terazosin for BPH. (J Fam Pract, 1995) [PMID:7533204]
- BPH: epidemiology and comorbidities. (Am J Manag Care, 2006) [PMID:16613526]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Terazosin in the treatment of benign prostatic hyperplasia: the United States experience. (1992) pubmed
- BPH: epidemiology and comorbidities. (2006) pubmed
- Benign prostatic hyperplasia. (1995) pubmed
- alpha(1)-blockers for BPH: are there differences? (1999) pubmed
- The efficacy and safety of terazosin for the treatment of symptomatic BPH. (1991) pubmed
- Terazosin for BPH. (1995) pubmed
- The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPH. (1992) pubmed
- Comparison of Anti BPH capsule (herbal) and Terazosin HCl in the treatment of benign prostate hyperplasia. (2017) pubmed
- Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders. (2004) pubmed
- Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia. (1997) pubmed